These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17673648)

  • 21. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
    Isgrò A; Leti W; De Santis W; Marziali M; Esposito A; Fimiani C; Luzi G; Pinti M; Cossarizza A; Aiuti F; Mezzaroma I
    Clin Infect Dis; 2008 Jun; 46(12):1902-10. PubMed ID: 18462177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Murine hematopoietic stem cell transduction using retroviral vectors.
    Modlich U; Schambach A; Li Z; Schiedlmeier B
    Methods Mol Biol; 2009; 506():23-31. PubMed ID: 19110617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications].
    Theze J
    Bull Acad Natl Med; 2008 Oct; 192(7):1453-66; discussion 1466-8. PubMed ID: 19445368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. All clear for HIV-targeting ribozyme in phase II.
    Brower V; Chahine K; Dorey E; Dove A; Francisco M; Hodgson J; Michael A; Marshall A
    Nat Biotechnol; 1998 Feb; 16(2):123. PubMed ID: 9487501
    [No Abstract]   [Full Text] [Related]  

  • 25. T cells for suicide gene therapy: activation, functionality and clinical relevance.
    Hollatz G; Grez M; Mastaglio S; Quaritsch R; Huenecke S; Ciceri F; Bonini C; Esser R; Klingebiel T; Kreuter J; Koehl U
    J Immunol Methods; 2008 Feb; 331(1-2):69-81. PubMed ID: 18155021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and characterization of a triple combination gene therapy vector inhibiting HIV-1 multiplication.
    Asparuhova MB; Barde I; Trono D; Schranz K; Schümperli D
    J Gene Med; 2008 Oct; 10(10):1059-70. PubMed ID: 18642399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insights into immunopathogenic mechanisms of HIV infection: high levels of immune activation and HIV fitness.
    Feller L; Khammissa RA; Wood NH; Meyerov R; Lemmer J
    SADJ; 2008 Nov; 63(10):552, 554, 556-7. PubMed ID: 19322966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular immunization or immunotherapy for HIV infection?
    Featherstone C
    Mol Med Today; 1996 Jul; 2(7):271. PubMed ID: 8796904
    [No Abstract]   [Full Text] [Related]  

  • 29. Chimpanzee CD4+ T cells are relatively insensitive to HIV-1 envelope-mediated inhibition of CD154 up-regulation.
    Rutjens E; Vermeulen J; Verstrepen B; Hofman S; Prins JM; Srivastava I; Heeney JL; Koopman G
    Eur J Immunol; 2008 Apr; 38(4):1164-72. PubMed ID: 18383039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of HIV-specific T and B cell responses with a replicating and conditionally infectious lentiviral vaccine.
    Wingard JB; Anderson B; Weissman D
    Eur J Immunol; 2008 May; 38(5):1310-20. PubMed ID: 18412164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene therapy to induce cellular resistance to HIV-1 infection: lessons from clinical trials.
    Giacca M
    Adv Pharmacol; 2008; 56():297-325. PubMed ID: 18086416
    [No Abstract]   [Full Text] [Related]  

  • 32. Sustained long-term engraftment and transgene expression of peripheral blood CD34+ cells transduced with third-generation lentiviral vectors.
    Tesio M; Gammaitoni L; Gunetti M; Leuci V; Pignochino Y; Jordaney N; Capellero S; Cammarata C; Caione L; Migliaretti G; Fagioli F; Tabilio A; Aglietta M; Piacibello W
    Stem Cells; 2008 Jun; 26(6):1620-7. PubMed ID: 18369098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunomagnetic enrichment of human and mouse hematopoietic stem cells for gene therapy applications.
    Guenechea G; Segovia JC; Bueren JA
    Methods Mol Biol; 2009; 506():1-11. PubMed ID: 19110615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Canine models of gene-modified hematopoiesis.
    Beard BC; Kiem HP
    Methods Mol Biol; 2009; 506():341-61. PubMed ID: 19110637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hematopoietic stem and progenitor cells in HIV/AIDS and immune reconstitution.
    Zhang J; Crumpacker CS
    Cell Res; 2010 Jul; 20(7):745-7. PubMed ID: 20567263
    [No Abstract]   [Full Text] [Related]  

  • 36. HIV/AIDS vaccines: 2007.
    Robinson HL
    Clin Pharmacol Ther; 2007 Dec; 82(6):686-93. PubMed ID: 17971817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of CXCR4 expression by SDF-KDEL in CD34(+) hematopoietic stem cells: An anti-human immunodeficiency virus strategy.
    Zhang JC; Sun L; Nie QH; Huang CX; Jia ZS; Wang JP; Lian JQ; Li XH; Wang PZ; Zhang Y; Zhuang Y; Sun YT; Bai X
    J Virol Methods; 2009 Oct; 161(1):30-7. PubMed ID: 19463855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineering immunity.
    von Bubnoff A
    IAVI Rep; 2008; 12(4):11-4. PubMed ID: 20213989
    [No Abstract]   [Full Text] [Related]  

  • 39. Pioneering HIV treatment would use interference and gene therapy.
    Check E
    Nature; 2005 Sep; 437(7059):601. PubMed ID: 16193002
    [No Abstract]   [Full Text] [Related]  

  • 40. HIV-1 Nef protein expression in human CD34+ progenitors impairs the differentiation of an early T/NK cell precursor.
    Dorival C; Brizzi F; Lelièvre JD; Sol-Foulon N; Six E; Henry A; André-Schmutz I; Cavazzana-Calvo M; Coulombel L; Estaquier J; Schwartz O; Lévy Y
    Virology; 2008 Jul; 377(1):207-15. PubMed ID: 18555888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.